LOGO
LOGO

Quick Facts

Prelude Therapeutics Appoints Charles Morris As Chief Medical Officer

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Prelude Therapeutics Incorporated (PRLD), a clinical-stage precision oncology company, said on Wednesday that Charles Morris will join the company as chief medical officer with effect from April 20.

Most recently, Morris served as chief medical officer at Lava Therapeutics. Prior to Lava, he had worked as chief medical officer for Celyad Oncology, Radius Health.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 08-12, 2026

June 12, 2026 17:14 ET
Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.